Arvind Sanger Cautiously Optimistic on India Eyes Earnings Revival
Spotify Surges 13 on AI Music Partnership with Universal Music Group and Upbeat Guidance
Consumer Sentiment Hits Record Low in May as Rising Gas Prices from Iran Conflict Weigh on Outlook
Paul Tudor Jones Sees No Chance Kevin Warsh Could Persuade Fed to Cut Rates
Custard Apple Gains Traction in Niche Fruit Markets Despite Export Hurdles
Retail Investors Gain Unprecedented Access to SpaceX IPO via Major Brokerage Platforms
Eagle Point Credit Company Inc ECC Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Declines
SBDS Q1 2026 Earnings Significant Loss Reported Amidst Operational Challenges
Worthington Steel Inc WS Q1 2026 Earnings EPS Misses Estimates Stock Still Rises
VRNS Q1 2026 Earnings Earnings Surprise Overshadows Missing Revenue Detail
RDWR Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction
VLYPO Q1 2026 Earnings Preferred Series B Reports Strong EPS Beat as Valley National Bancorp Outperforms Estimates
Brookfield Property Partners LP Preferred Stock BPYPN Holds Steady Near 14 Up 022
Alpha Metallurgical Resources Gains 178 as Coal Markets Show Resilience
Veris Residential VRE Hovers Near Support With Minimal Movement
Anika Therapeutics ANIK Slides 16 Amidst Market Pressure Key Levels to Watch
Broadstone Net Lease BNL Slips Slightly as Resistance Holds Firm
SpaceX OpenAI Valuations Could Surpass Berkshire Hathaway on Debut Trading Day Polymarket Traders Suggest
UDR Q1 2026 Earnings Massive EPS Beat of 413 Surprises Analysts
Dogwood Therapeutics Inches Lower as Stock Tests Key Support Near 169
Roper Technologies ROP Holds Steady at 31663 as Market Awaits Direction
Alcon Inc ALC Holds Steady Near Key Support as Traders Await Catalyst
SkyWest Inc SKYW Climbs 185 as Regional Aviation Demand Remains Robust
DAQO New Energy Slides as Solar Polysilicon Headwinds Persist
Barings Participation Investors MPV Gains 146 Testing Key Resistance at 1805
Sarepta Therapeutics SRPT Edges Higher Amid Modest Gains
MoonLake Immunotherapeutics MLTX Holds Near Support as Biotech Sector Sends Mixed Signals